rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
1999-9-14
|
pubmed:abstractText |
Understanding of the mechanisms of biotransformation of antidepressant drugs, and of their capacity to interact with other medications, is of direct relevance to rational clinical psychopharmacology.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/1-(3-chlorophenyl)piperazine,
http://linkedlifedata.com/resource/pubmed/chemical/Alprazolam,
http://linkedlifedata.com/resource/pubmed/chemical/Antidepressive Agents,
http://linkedlifedata.com/resource/pubmed/chemical/CYP3A protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Cytochrome P-450 CYP3A,
http://linkedlifedata.com/resource/pubmed/chemical/Cytochrome P-450 Enzyme System,
http://linkedlifedata.com/resource/pubmed/chemical/Mixed Function Oxygenases,
http://linkedlifedata.com/resource/pubmed/chemical/Piperazines,
http://linkedlifedata.com/resource/pubmed/chemical/Triazoles,
http://linkedlifedata.com/resource/pubmed/chemical/nefazodone
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0033-3158
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
145
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
113-22
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:10445380-Alprazolam,
pubmed-meshheading:10445380-Antidepressive Agents,
pubmed-meshheading:10445380-Biotransformation,
pubmed-meshheading:10445380-Cytochrome P-450 CYP3A,
pubmed-meshheading:10445380-Cytochrome P-450 Enzyme System,
pubmed-meshheading:10445380-Drug Interactions,
pubmed-meshheading:10445380-Humans,
pubmed-meshheading:10445380-Hydroxylation,
pubmed-meshheading:10445380-Microsomes, Liver,
pubmed-meshheading:10445380-Mixed Function Oxygenases,
pubmed-meshheading:10445380-Piperazines,
pubmed-meshheading:10445380-Triazoles
|
pubmed:year |
1999
|
pubmed:articleTitle |
Nefazodone, meta-chlorophenylpiperazine, and their metabolites in vitro: cytochromes mediating transformation, and P450-3A4 inhibitory actions.
|
pubmed:affiliation |
Division of Clinical Pharmacology, New England Medical Center Hospital, Boston, Massachusetts, USA. Lvonmoltke@Infonet.tufts.edu
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|